This TSX 60 Tech Stock Has Raised its Dividend for Over 25 Consecutive Years

Not many TSX tech stocks have a 28-year history of growing dividends. Here is one top stock that does, and you don’t want to miss it!

| More on:

Technology stocks with growing dividends are not a combination you find often on the TSX. Yet, one TSX 60 tech stock stands out above the rest. It is Thomson Reuters (TSX:TRI)(NYSE:TRI). In fact, it is the only technology stock in Canada to have paid and raised its annual dividend for the past 28 consecutive years. Since 2012, it has returned $27 billion of capital back to its shareholders. Today, this TSX stock pays a dividend that equals to $2.06 per share annually. That is equivalent to a 1.5% dividend yield.

A top TSX tech stock that has raised its dividend for years

Is this TSX tech/dividend stock a good company?

Certainly, that is an impressive metric, but does that make this company a good TSX stock going forward? Generally, a company that consistently raises its dividend over many, many years is a good sign. It means the company produces more capital than it needs to both sustain and grow its business. Clearly, management is capable of prudently managing its balance sheet, and it capably produces more free cash flow than it needs.

To understand Thomson Reuters better, let us first ask what it does. Through the years, this TSX stock has built a leading content platform for the legal, tax, corporate, and news/media industry. You are probably familiar with its Reuters newswire service. However, that only makes up a very small piece of its business. Today, 79% of its revenues come from legal, corporate services, and accounting/tax business segments.

Dominant market position

Across these segments, it has the number one market position amongst competitors. Consequently, this TSX stock has the scale and authority to really dominate these niches. Generally, revenues are very sticky. It retains over 88% of its customers annually. Across all its business segments, 80% of revenues are recurring and 90% of revenues are delivered electronically or through Software as a Service.

Overall, its leading position gives it a competitive moat and an advantage to grow. It owns a vast array of data, information, and content that it is formulating into new organic software growth verticals. In fact, over the next two years, it is targeting annual organic growth of 4-5% and 5-6% in 2023. Not only that, but adjusted EBITDA margins in that time frame are expected to climb from 31% today to 38-40% in 2023.

Steady growth and rising profitability

While I like to see a company grow, it is even better to see them become more profitable at the same time. This year, Thomson Reuters expects to earn at least $1.1 billion in free cash flow. If it can execute its plan, management believes the business could churn out close to $2 billion (or almost twice as much) cash flow in 2023. To me, that just spells more shareholder-friendly actions like share buybacks and dividend increases.

One thing to keep in mind is that this TSX stock does have a fair amount of debt. It has $3.7 billion of debt outstanding. Fortunately, it is also sitting on a cash balance of $2.3 billion. That means net debt-to-adjusted EBITDA only sits at 0.8 times. Given its stable recurring revenue and strong free cash flow profile, management appears pretty confident in its capital position. Prudent debt could be a further tool to help accelerate growth beyond.

This TSX tech stock should grow its dividend for years to come

Sure, this TSX stock is not growing rapidly like other technology stocks. However, its industry dominance, strong profitability, organic growth, and consistent dividend growth make it pretty attractive. This stock is not exactly cheap here, and the market appears pretty optimistic about its outlook. However, for a long-term buy-and-hold investor, buy Thomson Reuters stock and let the dividend growth keep coming for another 20 years.

Fool contributor Robin Brown has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

Rocket lift off through the clouds
Tech Stocks

2 Growth Stocks Set to Skyrocket in 2026 and Beyond

Growth stocks like Blackberry and Well Health Technologies are looking forward to leveraging strong opportunities in their respective industries.

Read more »

Happy golf player walks the course
Tech Stocks

The January Reset: 2 Beaten-Down TSX Stocks That Could Stage a Comeback

A January TFSA reset can work best with “comeback” stocks that still have real cash engines, not just hype.

Read more »

investor looks at volatility chart
Tech Stocks

1 Magnificent Canadian Tech Stock Down 38% to Buy and Hold for Decades

Constellation Software is a TSX tech stock that offers significant upside potential to shareholders over the next 12 months.

Read more »

AI concept person in profile
Tech Stocks

Tech’s January Bounce: 2 Canadian Stocks That Could Lead a 2026 Rebound

A January tech bounce can happen fast when fresh money and improving mood push investors back into overlooked Canadian names.

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

2 Stocks Retirees Should Absolutely Love

Discover strategies for managing stocks during retirement, especially in light of market uncertainties and downturns.

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

Down 38%, This Magnificent Canadian Stock Could Be the Biggest Bargain on the TSX Today

Constellation Software (TSX:CSU) was a tough hold in 2025, could the new year be a turning point.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

Meet the Canadian Semiconductor Stock Up 150% This Year

Given its healthy growth outlook and reasonable valuation, 5N Plus would be a compelling buy at these levels.

Read more »

money goes up and down in balance
Tech Stocks

1 Magnificent Canadian Stock Down 26% to Buy and Hold Forever

Lightspeed isn’t the pandemic high-flyer anymore and that reset may be exactly what gives patient investors a better-risk, better-price entry…

Read more »